Skip to Main Content

Paper Details

Development of mRNA manufacturing for vaccines and therapeutics: mRNA platform requirements and development of a scalable production process to support early phase clinical trials.
28
2022
Author NameAffiliation
Drew WeissmanPerelman School of Medicine, University of Pennsylvania
Barton F HaynesDuke Human Vaccine Institute, Duke University School of Medicine
  • 1 - 2

Datasets

Release 1.2